- Oops!Something went wrong.Please try again later.
Shares of IntriCon (NASDAQ:IIN) were flat in after-market trading after the company reported Q4 results.
Earnings per share rose 50.00% year over year to $0.12, which beat the estimate of $0.04.
Revenue of $30,301,000 rose by 9.41% year over year, which beat the estimate of $27,350,000.
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Feb 25, 2021
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/y6bpms6j
52-week high: $23.18
52-week low: $9.84
Price action over last quarter: Up 45.46%
IntriCon Corp design, develop and manufacture miniature and micro-miniature body-worn medical and electronics products. The company has two operating segments, the Body-Worn Device segment (consisting of three markets: medical, hearing health, and professional audio), and the Hearing Health Direct-to-Consumer segment. Its primary geographic markets are the United States, Europe, Asia, and all other countries. The company serves a diverse range of markets including the hearing healthcare market, the medical biotelemetry market, and the professional audio communication market.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.